Fri, Feb 27, 2015, 4:34 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Oxygen Biotherapeutics, Inc. Message Board

  • dealerschoice10 dealerschoice10 Nov 7, 2013 7:19 PM Flag

    ALSO, AH MEANS NOTHING, FUNDS WERE BUYING AS EVERYONE WAS SELLING TODAY

    Retail means nothing, the big boys know this stock is going to go nuts, panic retail selling just gave them the opportunity to load huge today. It's just unreal how it works, but when you see this run to $9 tomorrow you'll know what i'm saying.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Under the base case, an average EV/Sales multiple of 5.9x is applied to $31.20 million in sales. Full dilution is assumed. Oxygen Biotherapeutics' target Enterprise Value is $184 million leading to a target share price of $21.71.

      Under the bull case, full dilution is assumed. A peak EV/Sales multiple of 7.27x is applied to $151.2 million in sales, Oxygen Biotherapeutics's target Enterprise Value is $1.1 million leading to a target share price of $130.01.

      The table below illustrates each scenario with the probability of each scenario in the first column.

      (click to enlarge)

      Overall, using very conservative estimates and placing a very high probability on the base case, out weighted average approach leads to a target share price of $32.96, which represents 984% upside.

 
OXBT
4.040.00(0.00%)Sep 18 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.